Mr. Braglia holds a degree in Business Economics with a specialization in Business Management from the Bocconi University of Milan. He has 30 years of international experience in the pharmaceutical industry. Mr. Braglia heads the family run, privately owned pharmaceutical company, the Helsinn Group, founded in 1976 by his father, Gabriele Braglia. He has transformed it into an international group with operating subsidiaries in Switzerland, Ireland, the US and a representative office in China. Over the last 40 years Helsinn has built a worldwide presence with a focus on cancer supportive care. Mr. Braglia is also active in the investment community as an advisor to the New York City-based venture capital firm Windham Ventures.